- Home
- POAI vs GGZ Comparison
POAI vs GGZ Comparison
Compare POAI & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- GGZ
- Stock Information
- Founded
- POAI 2002
- GGZ 2013
- Country
- POAI United States
- GGZ United States
- Employees
- POAI 35
- GGZ N/A
- Industry
- POAI Industrial Specialties
- GGZ Investment Managers
- Sector
- POAI Health Care
- GGZ Finance
- Exchange
- POAI Nasdaq
- GGZ Nasdaq
- Market Cap
- POAI 9.9M
- GGZ N/A
- IPO Year
- POAI N/A
- GGZ N/A
- Fundamental
- Price
- POAI $1.30
- GGZ $11.05
- Analyst Decision
- POAI Hold
- GGZ
- Analyst Count
- POAI 1
- GGZ 0
- Target Price
- POAI N/A
- GGZ N/A
- AVG Volume (30 Days)
- POAI 8.1M
- GGZ 12.8K
- Earning Date
- POAI 05-13-2025
- GGZ 01-01-0001
- Dividend Yield
- POAI N/A
- GGZ 5.39%
- EPS Growth
- POAI N/A
- GGZ N/A
- EPS
- POAI N/A
- GGZ 1.75
- Revenue
- POAI $1,623,817.00
- GGZ N/A
- Revenue This Year
- POAI $486.27
- GGZ N/A
- Revenue Next Year
- POAI $65.50
- GGZ N/A
- P/E Ratio
- POAI N/A
- GGZ $6.79
- Revenue Growth
- POAI N/A
- GGZ N/A
- 52 Week Low
- POAI $0.55
- GGZ $9.43
- 52 Week High
- POAI $3.06
- GGZ $12.50
- Technical
- Relative Strength Index (RSI)
- POAI 48.03
- GGZ 39.44
- Support Level
- POAI $1.26
- GGZ $12.23
- Resistance Level
- POAI $1.58
- GGZ $12.10
- Average True Range (ATR)
- POAI 0.21
- GGZ 0.19
- MACD
- POAI 0.01
- GGZ -0.05
- Stochastic Oscillator
- POAI 16.13
- GGZ 45.34
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.